Jochen Lorch, MD
Hematology & Oncology · Chicago, ILNPI 1518913094
Payments from drug & device makers
Across 94 payments — averaging $33,987 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1.6M
- Takeda Pharmaceuticals U.S.A., Inc.$675K
- Eli Lilly$362K
- Exelixis Inc.$146K
- Astellas Pharma Global Development$82K
- Bayer$74K
- plus $218K from 12 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 9 | $1,637,739 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $675,033 |
| Eli Lilly | 2 | $361,737 |
| Exelixis Inc. | 15 | $145,966 |
| Astellas Pharma Global Development | 26 | $82,116 |
| Bayer | 12 | $74,241 |
| Regeneron | 1 | $60,708 |
| Secura Bio, Inc. | 4 | $58,084 |
| Seagen Inc. | 5 | $52,208 |
| Pfizer | 1 | $36,754 |
| Eisai Inc. | 4 | $5,871 |
| Coherus Oncology, Inc. | 3 | $2,298 |
| Janssen Scientific Affairs, LLC | 1 | $1,763 |
| SK Life Science, Inc. | 1 | $105 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Morphosys, US Inc. | 1 | $23 |
| Merck | 1 | $20 |
| AstraZeneca | 1 | $15 |
How this compares
$3,194,731 in reported general payments places this provider in the 95th percentile of 580 hematology & oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Chicago
- Oana DanciuChicago$23.2M
- Shuo MaChicago$20.5M
- Olwen HahnChicago$11.9M
- Christine BestvinaChicago$11.3M
- Russell SzmulewitzChicago$9.8M
- Randy SweisChicago$9.4M
- Hedy KindlerChicago$8.6M
- Reem KarmaliChicago$7.7M
- Wendy StockChicago$7.2M
- Justin KlineChicago$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.